Invesco Ltd. Axogen, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 48,383 shares of AXGN stock, worth $685,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,383

Previous 382,429 87.35%

Holding current value

$685,103

Previous $7.07 Million 92.59%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$9.29 - $17.81 $3.1 Million - $5.95 Million	-334,046 Reduced 87.35%	48,383 $524,000
Q1 2025 May 12, 2025	BUY	$14.56 - $20.11 $5.32 Million - $7.34 Million	365,237 Added 2124.46%	382,429 $7.07 Million
Q4 2024 Feb 13, 2025	SELL	$12.47 - $17.19 $3.25 Million - $4.47 Million	-260,294 Reduced 93.8%	17,192 $283,000
Q3 2024 Nov 12, 2024	BUY	$7.52 - $14.69 $1.75 Million - $3.42 Million	232,925 Added 522.71%	277,486 $3.89 Million
Q2 2024 Aug 13, 2024	BUY	$5.67 - $8.06 $157,637 - $224,084	27,802 Added 165.89%	44,561 $322,000
Q1 2024 May 14, 2024	SELL	$6.63 - $10.69 $6,941 - $11,192	-1,047 Reduced 5.88%	16,759 $135,000
Q4 2023 Feb 12, 2024	SELL	$3.61 - $7.76 $16,457 - $35,377	-4,559 Reduced 20.38%	17,806 $121,000
Q3 2023 Nov 13, 2023	BUY	$4.68 - $9.26 $6,435 - $12,732	1,375 Added 6.55%	22,365 $111,000
Q2 2023 Aug 11, 2023	BUY	$8.5 - $10.38 $37,740 - $46,087	4,440 Added 26.83%	20,990 $191,000
Q1 2023 May 12, 2023	SELL	$7.53 - $10.95 $2,658 - $3,865	-353 Reduced 2.09%	16,550 $156,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $4,625 - $6,414	490 Added 2.99%	16,903 $168,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $17,549 - $26,411	2,156 Added 15.12%	16,413 $196,000
Q2 2022 Aug 15, 2022	SELL	$6.99 - $10.0 $15,867 - $22,700	-2,270 Reduced 13.74%	14,257 $117,000
Q1 2022 May 16, 2022	SELL	$7.26 - $10.7 $2,148 - $3,167	-296 Reduced 1.76%	16,527 $131,000
Q4 2021 Feb 14, 2022	SELL	$8.8 - $16.0 $45,170 - $82,128	-5,133 Reduced 23.38%	16,823 $158,000
Q3 2021 Nov 15, 2021	BUY	$15.23 - $21.72 $68,367 - $97,501	4,489 Added 25.7%	21,956 $348,000
Q2 2021 Aug 17, 2021	BUY	$17.8 - $23.5 $310,912 - $410,474	17,467 New	17,467 $378,000
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $282,284 - $371,340	-16,431 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.5 - $17.96 $53,072 - $82,885	4,615 Added 39.06%	16,431 $294,000
Q3 2020 Nov 16, 2020	SELL	$10.62 - $13.12 $2,198 - $2,715	-207 Reduced 1.72%	11,816 $138,000
Q2 2020 Aug 14, 2020	SELL	$7.35 - $10.81 $38,271 - $56,287	-5,207 Reduced 30.22%	12,023 $111,000
Q1 2020 May 15, 2020	BUY	$8.38 - $17.34 $144,387 - $298,768	17,230 New	17,230 $179,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $654,752 - $901,434	-35,392 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $517,431 - $783,224	35,392 New	35,392 $745,000

Others Institutions Holding AXGN

# of Institutions

168

Shares Held

40.1M

Call Options Held

69.1K

Put Options Held

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $599M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account